Q1 2024 Holdings
Filed 2024-05-13 | 6 holdings | $364.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $163.2M | 2,346,630 | 44.8% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $71.5M | 1,048,951 | 19.6% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $41.0M | 4,012,903 | 11.3% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $36.0M | 3,333,333 | 9.9% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $26.3M | 6,526,476 | 7.2% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $26.0M | 2,016,822 | 7.2% |